Category: Finance

February 2026 has produced a notably uneven tape for technology: broad market strength has been punctuated by repeated “safe haven” rotations into energy and staples, while higher-beta AI-linked equities have absorbed sharp drawdowns. In that context, 20–30% pullbacks can look less like a verdict on AI demand and more like a repricing of duration, volatility, and expectations.

For disciplined investors, this kind of “white noise” is often where entry points appear—particularly when underlying company fundamentals (revenue, earnings, and forward guidance) are improving quarter over quarter even as the stock price retraces.

Key takeaways

• Market leadership has broadened unevenly: defensive rotations can coexist with steep pullbacks in high-beta AI names.
• AI adoption has shifted from experimentation to operational efficiency (software development, data-center management, and healthcare workflows), supporting demand for hardware and specialized software.
• In the current dataset, top AI quant picks show materially higher projected growth than both the “Magnificent Seven” and the broader S&P 500.
• Short-term sentiment can obscure signal; revision trends and the “staircase” pattern in revenue/EPS are often more informative than headline-driven price action.

A tale of two markets: rallies and rotations

Recent price action has been characterized by an on/off risk regime. On “risk-on” days, broad indices can rally; conversely, those rallies have frequently been interrupted by capital rotating into perceived defensives such as energy and consumer staples. This push-pull dynamic matters because it compresses holding periods and increases the odds that high-volatility segments—especially AI-linked growth equities—overshoot to the downside.

High-beta AI stocks falling 20–30% in a month is attention-grabbing, but it is not automatically diagnostic of weakening adoption. In many cases, these moves reflect a combination of valuation reset, risk-parity deleveraging, and crowded positioning unwinds. The practical implication is straightforward: when price declines are driven more by macro/positioning than by deteriorating fundamentals, fundamentals-based screening becomes more useful, not less.

From experimental to “broad” AI: where demand is showing up

AI deployment has increasingly moved beyond pilots and proofs of concept. The dominant use case in 2026 is operational efficiency: writing and maintaining code, managing and optimizing data centers, and improving clinical and diagnostic workflows in healthcare. Moreover, these workflows are not “AI-only” projects; they are blended into existing software stacks, infrastructure procurement, and enterprise budgeting cycles.

In this regard, demand can be expressed through two complementary channels:

• Hardware and infrastructure: compute, connectivity, and manufacturing capacity needed to deploy and run AI at scale.
• Specialized software: tooling that makes AI systems usable, measurable, and economically productive in real business processes.

Within the current comparison set, “top AI picks” show a projected revenue growth rate of 38%, versus 6% for the broader S&P 500. That spread is large enough that it can dominate the investment outcome if it persists, even after accounting for volatility and valuation compression.

Growth comparison: AI picks vs. mega-cap tech vs. the index

Group	Revenue growth	EPS growth
Top AI quant picks	38%	99%
Magnificent Seven	17%	20%
S&P 500	6%	10.6%

The key point is not that mega-cap tech is “bad” or that the index is “irrelevant.” Rather, it is that the growth differential can justify looking beyond the largest names—particularly when price drawdowns have improved prospective entry points for smaller or mid-cap companies tied to AI infrastructure and applied AI.

Five AI-linked names to watch during the 2026 dip (Group B)

The following tickers are presented as a focused watchlist rather than a blanket recommendation. They span software, infrastructure manufacturing, semiconductors/connectivity, and healthcare equipment—areas where AI spending tends to show up as measurable demand for products and services.

Hut 8 Corp (HUT)

Category: application software. One notable datapoint in the current profile is the improvement in profitability, moving from D- to A+. If that trajectory is durable, it can change how the market values the business (profitability and cash flow tend to matter more when volatility is elevated).

Celestica (CLS)

Category: electronic manufacturing. With a stated 43% long-term growth rate and a role in AI infrastructure, this name can be viewed as an “enabler” rather than a pure software narrative. Manufacturing and integration capacity are frequently bottlenecks when adoption accelerates.

Credo Technology (CRDO)

Category: connectivity microchips. The stock has experienced a 28% monthly pullback alongside reported 105% revenue growth. This is a good illustration of the current regime: strong growth metrics do not immunize a name from a valuation reset. Conversely, a sharp pullback can improve forward returns if the growth profile persists.

Revision activity can also matter here: the current snapshot notes 12 upward revisions in 90 days and 0 downward. While revisions are not a guarantee, they often reflect improving expectations that may not yet be fully reflected in the price.

AppLovin (APP)

Profile: A+ growth and profitability. In a market that intermittently rewards defensiveness, the combination of growth and profitability can be a differentiator. The analytical task is to confirm that profitability is not a one-off (e.g., driven by temporary margin factors) and that growth is not overly dependent on a single channel or customer concentration.

Globus Medical (GMED)

Theme: AI applied to medical equipment and surgical optimization. The profile includes 68% EBIT growth. Healthcare is often a slower adoption domain; however, when AI is embedded in workflow and instrumentation, progress can be incremental and measurable rather than purely conceptual.

Filtering signal from noise: sentiment, insider selling, and revisions

When volatility is high, narrative tends to expand. It is tempting to anchor on daily commentary, viral takes, and short-term price moves. Conversely, a more stable approach is to prioritize what changes slowly and compounds: revenue, earnings power, and the forward expectation set.

Insider selling is a common source of headline anxiety, but it is not always a clean signal of negative conviction; compensation structure and diversification can drive sales even when the underlying business is healthy. Meanwhile, analyst estimate revisions—especially when they trend consistently in one direction—can serve as a practical summary of how the expectation set is moving.

A useful mental model is the “staircase” pattern: when revenue and EPS increase quarter over quarter, the fundamentals are climbing even if price is temporarily falling. In that setup, a dip can be a gift rather than a warning—provided the next few quarters continue to validate the trend.

Caveats and limits

• High growth does not eliminate risk. 20–30% drawdowns can repeat, and liquidity can vanish quickly in risk-off rotations.
• Revisions can reverse. Upward estimate changes are helpful context, but they can lag real-time business conditions and can shift rapidly after guidance updates.
• Mix matters. Revenue growth and EPS growth are summary metrics; margin sustainability, customer concentration, and capex intensity can materially change the investment profile.
• Watch valuation and duration. Even strong businesses can underperform if multiples compress due to rates, risk premia, or changing market regimes.

Practical checklist for the 2026 pullback

For investors considering AI exposure beyond the largest index constituents, a disciplined process can reduce the odds of confusing volatility with deterioration:

• Confirm that revenue and EPS are improving quarter over quarter (the “staircase,” not a single spike).
• Track estimate revisions around earnings and guidance updates; treat dispersion as a risk indicator.
• Separate macro-driven drawdowns from company-specific breaks (product demand, competitive losses, or margin impairment).
• Size positions for volatility; assume that pullbacks can deepen before fundamentals reassert themselves.

Early 2026 has brought sharp swings in AI-related equities—an echo of last year’s “DeepSeek” dip—where narrative and positioning can move prices faster than underlying business performance. The core question is whether the current drawdowns reflect deteriorating adoption, or a temporary repricing driven by macro conditions and sentiment.

This article examines the “buy-the-dip” logic through a multi-factor lens, clarifies what common quant factors are actually measuring, and highlights the limits of translating factor scores into decisions. (This is not investment advice.)

Key takeaways

• Headline-driven volatility can obscure whether fundamentals (growth, profitability, cash flow) are improving or deteriorating.
• A multi-factor framework typically blends valuation and growth (often described as “GARP”) with momentum and analyst estimate changes.
• “Hold” in a factor system is usually a monitoring stance, not an automatic exit signal; “Sell” tends to reflect worsening factor inputs relative to peers.
• Even if the long-run AI market expands substantially, individual stocks can still disappoint due to competition, cyclicality, and over-optimistic forecasts.

Why AI volatility can be loud when the data is quieter

When macro uncertainty rises—geopolitical tensions, shifting Federal Reserve expectations—investors often compress risk quickly. In such environments, the most crowded themes (including AI infrastructure and “AI-adjacent” hardware) can experience amplified moves because positioning and sentiment become the marginal driver of price action.

Moreover, the presence of a widely remembered prior dip matters. Market participants anchor to past episodes and re-run the same playbook—sometimes wisely, sometimes mechanically. The “buy-the-dip” interpretation is plausible, but it rests on one premise: the fundamentals being measured are robust, comparable across firms, and not merely artifacts of a favorable part of the cycle.

What a multi-factor quant system is measuring (and what it isn’t)

A typical quant framework uses five factor families:

• Growth
• Value
• Profitability
• Momentum
• Analyst revisions

In practical terms, these factors try to separate “the company is improving” from “the stock is popular.” For example:

• Growth typically proxies revenue and earnings expansion over time.
• Value captures how expensive the stock is relative to fundamentals (e.g., P/E and related ratios).
• Profitability distinguishes durable earners from firms that are only scaling top-line.
• Momentum measures trend persistence—useful in practice, but inherently backward-looking.
• Analyst revisions track changes in consensus expectations; upgrades can reflect improved outlooks, but can also follow price.

This framework often emphasizes GARP (“Growth at a Reasonable Price”). In principle, GARP avoids two failure modes: paying too much for growth, or buying “cheap” companies whose fundamentals are cheap for a reason. Conversely, GARP is not a guarantee that growth persists, nor that “reasonable” valuations cannot become unreasonable if macro conditions tighten further.

The macro claim: a large AI market does not eliminate stock risk

A commonly cited projection is that the global AI market could reach $3 trillion by 2033, supported by infrastructure investment and adoption in manufacturing, healthcare, and energy.

That style of estimate can be useful context: it suggests a long runway for spending and deployment. Furthermore, it helps explain why some AI-exposed companies trade at elevated multiples—investors are paying for expected future cash flows rather than present-day earnings.

However, a large total addressable market (TAM) is not the same thing as capture. Even if the market expands substantially, individual firms can lose pricing power, face new entrants, or see margins compress as customers standardize. In this regard, the bridge between “AI is big” and “this stock is attractive” is whether a company has defensible differentiation and the ability to turn demand into cash flow.

High P/E ratios can be rational if forward EPS growth remains meaningfully above the broad market. The key issue is forecast reliability: forward EPS paths can be revised downward quickly in cyclical segments, especially semiconductors and related supply chains.

Top quant-rated AI tickers mentioned (and what the bullet points imply)

Using the provided “Group A” framing, five names are highlighted across different parts of the AI ecosystem:

• LITE (Lumentum Holdings) — A+ Growth; 61% 3–5 year CAGR.
• MU (Micron Technology) — 51% long-term CAGR; DRAM/NAND.
• CIEN (Ciena Corp) — Significant analyst revisions; B+ Profitability.
• GM (General Motors) — AI integration for hands-free driving; B- Valuation.
• TSM (Taiwan Semiconductor) — 69% EBITDA margin; 51% discount on a PEG basis.

A few definitions help interpret those datapoints:

• Operating cash flow growth focuses on cash generation from core operations; it can be more informative than earnings during periods with heavy non-cash charges, but it can still swing with working capital.
• DRAM/NAND refers to memory and storage markets that can be essential to AI infrastructure, but are historically cyclical.
• EBITDA margin approximates operating profitability before certain expenses; it is not the same as free cash flow, particularly for capital-intensive businesses.
• PEG is the price/earnings ratio adjusted by growth; a “discount on a PEG basis” implies price is low relative to expected growth, but it inherits the uncertainty of growth forecasts.

These bullets should be treated as hypotheses to verify rather than conclusions to accept. “Forward” cash flow and growth rates embed assumptions about demand, pricing, and cost structure—precisely the inputs that can change when a theme becomes crowded or macro conditions tighten.

“Hold” vs. “Sell”: monitoring, not drama

In many quant systems, a Hold rating is not a command to exit. It signals that the position remains acceptable, but warrants monitoring for deterioration.

Conversely, a Sell or Strong Sell tends to occur when the data—profitability, analyst revisions, and other factor inputs—indicates that a company is losing ground relative to sector peers. This is a disciplined approach in concept: it formalizes what many discretionary investors attempt informally (tracking whether the story is improving or degrading).

Nevertheless, factor-based “sell signals” can lag abrupt regime changes. Moreover, analyst revisions can be pro-cyclical: estimates often rise after a rally and fall after a drawdown, which can amplify trend-following behavior rather than counterbalance it.

Caveats and limits

• Quant ratings depend on inputs. If underlying metrics are noisy (or not comparable across industries), outputs can look precise while being fragile.
• Forward estimates can be wrong. P/E, PEG, and forward cash flow growth embed assumptions; revisions can arrive abruptly, particularly in cyclical hardware segments.
• Valuation is not timing. A stock can be “attractive” on paper and still decline if risk premiums rise or liquidity tightens.
• AI exposure varies widely. “AI-related” can mean direct model revenue, infrastructure, components, or operational use of AI—each has different sensitivity to cycles and competition.

Bottom line

The disciplined interpretation is not “buy everything labeled AI,” but rather: define the factors you trust, check whether improvement is fundamental (cash flow, profitability, credible growth), and treat “Hold” as an instruction to monitor—not to panic. Furthermore, keep a clear view of what the model does not capture: structural competition, regime shifts, and the fact that forecasts are not outcomes.